Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Journal of Allergy and Clinical Immunology - Tập 146 - Trang 110-118 - 2020
Xiaochen Li1,2, Shuyun Xu1,2, Muqing Yu1,2, Ke Wang1,2, Yu Tao1,2, Ying Zhou1,2, Jing Shi1,2, Min Zhou1,2, Bo Wu3, Zhenyu Yang1,2, Cong Zhang1,2, Junqing Yue1,2, Zhiguo Zhang4, Harald Renz5, Xiansheng Liu1,2, Jungang Xie1,2, Min Xie1,2, Jianping Zhao1,2
1Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Key Laboratory of Respiratory Diseases, National Ministry of Health of the People’s Republic of China and National Clinical Research Center for Respiratory Disease, Wuhan, China
3United Imaging Healthcare Co Ltd, Wuhan, China
4School of Medicine and Health Management, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics Philipps University Marburg, University Hospital Giessen and Marburg GmbH, Marburg, Germany.

Tài liệu tham khảo

Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8 Metlay, 2019, Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, Am J Respir Crit Care Med, 200, e45, 10.1164/rccm.201908-1581ST Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032. He, 2006, Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS, J Pathol, 210, 288, 10.1002/path.2067 Lam, 2004, Severe acute respiratory syndrome: clinical and laboratory manifestations, Clin Biochem Rev, 25, 121 Sheng, 2005, Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome, J Formos Med Assoc, 104, 715 Zhu, 2004, SARS immunity and vaccination, Cell Mol Immunol, 1, 193 Huang, 2019, Prevalence, risk factors, and management of asthma in China: a national cross-sectional study, Lancet, 394, 407, 10.1016/S0140-6736(19)31147-X Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print February 19, 2020]. Allergy. https://doi.org/10.1111/all.14238. Wang, 2016, An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011, Allergy, 71, 1170, 10.1111/all.12874 Hashimoto, 2012, ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation, Nature, 487, 477, 10.1038/nature11228 Chai, 2020, Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection, bioRxiv Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4 Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print March 13, 2020]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis [published online ahead of print March 26, 2020]. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020. Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712 Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med, 11, 875, 10.1038/nm1267 Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786 Erez, 2014, Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients, Isr Med Assoc J, 16, 439 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print February 24, 2020]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print March 18, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282. Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 514, 10.1016/S0140-6736(20)30154-9 Rothe, 2020, Transmission of 2019-nCoV infection from an asymptomatic contact in Germany, N Engl J Med, 382, 970, 10.1056/NEJMc2001468 Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19 [published online ahead of print February 27, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2783. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? [published online ahead of print February 22, 2020] Int J Epidemiol. https://doi.org/10.1093/ije/dyaa033.